Chemoinformaics analysis of 2-Ethyl-2,3-epoxypropanol
| Molecular Weight | 102.133 | nRot | 2 |
| Heavy Atom Molecular Weight | 92.053 | nRig | 1 |
| Exact Molecular Weight | 102.068 | nRing | 1 |
| Solubility: LogS | -7.045 | nHRing | 1 |
| Solubility: LogP | 8.463 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 16.6219 |
| nHD | 1 | BPOL | 11.7681 |
| QED | 0.235 |
| Synth | 1.819 |
| Natural Product Likeliness | 0.598 |
| NR-PPAR-gamma | 0.143 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.784 |
| MDCK | 0.0000108 |
| BBB | 0.201 |
| PPB | 1.00095 |
| VDSS | 2.927 |
| FU | 0.0116948 |
| CYP1A2-inh | 0.32 |
| CYP1A2-sub | 0.191 |
| CYP2c19-inh | 0.411 |
| CYP2c19-sub | 0.068 |
| CYP2c9-inh | 0.124 |
| CYP2c9-sub | 0.942 |
| CYP2d6-inh | 0.337 |
| CYP2d6-sub | 0.241 |
| CYP3a4-inh | 0.448 |
| CYP3a4-sub | 0.059 |
| CL | 4.356 |
| T12 | 0.068 |
| hERG | 0.143 |
| Ames | 0.011 |
| ROA | 0.028 |
| SkinSen | 0.966 |
| Carcinogencity | 0.058 |
| EI | 0.959 |
| Respiratory | 0.306 |
| NR-Aromatase | 0.018 |
| Antiviral | No |
| Prediction | 0.939276 |